Education
About Us
Working with TipRanks
Follow Us
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
Total Valuation
Celldex has a market cap or net worth of $1.95B. The enterprise value is $1.93B.
Market Cap$1.95B
Enterprise Value$1.93B
Share Statistics
Celldex has 66,566,345 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding66,566,345
Owned by Insiders0.36%
Owned by Institutions10.17%
Financial Efficiency
Celldex’s return on equity (ROE) is -0.49 and return on invested capital (ROIC) is -53.87%.
Return on Equity (ROE)-0.49
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)-53.87%
Return on Capital Employed (ROCE)-0.54
Revenue Per Employee8.06K
Profits Per Employee-1.39M
Employee Count186
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Celldex is ―. Celldex’s PEG ratio is -0.12.
PE Ratio―
PS Ratio1204.09
PB Ratio3.43
Price to Fair Value3.43
Price to FCF-8.45
Price to Operating Cash Flow-9.28
PEG Ratio-0.12
Income Statement
In the last 12 months, Celldex had revenue of 1.50M and earned -258.80M in profits. Earnings per share was -3.90.
Revenue1.50M
Gross Profit1.50M
Operating Income-287.40M
Pretax Income-258.80M
Net Income-258.80M
EBITDA-255.42M
Earnings Per Share (EPS)-3.90
Cash Flow
In the last 12 months, operating cash flow was -210.94M and capital expenditures -2.43M, giving a free cash flow of -213.37M billion.
Operating Cash Flow-210.94M
Free Cash Flow-213.37M
Free Cash Flow per Share-3.21
Dividends & Yields
Celldex pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change50.46%
50-Day Moving Average26.05
200-Day Moving Average24.41
Relative Strength Index (RSI)63.12
Average Volume (3m)836.01K
Important Dates
Celldex upcoming earnings date is Apr 30, 2026, After Close (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
Celldex as a current ratio of 10.49, with Debt / Equity ratio of 0.44%
Current Ratio10.49
Quick Ratio10.49
Debt to Market Cap<0.01
Net Debt to EBITDA0.10
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Celldex has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Celldex EV to EBITDA ratio is -6.97, with an EV/FCF ratio of -8.33.
EV to Sales1.19K
EV to EBITDA-6.97
EV to Free Cash Flow-8.33
EV to Operating Cash Flow-8.44
Balance Sheet
Celldex has $518.57M in cash and marketable securities with $2.34M in debt, giving a net cash position of $516.24M billion.
Cash & Marketable Securities$518.57M
Total Debt$2.34M
Net Cash$516.24M
Net Cash Per Share$7.76
Tangible Book Value Per Share$7.52
Margins
Gross margin is 100.00%, with operating margin of -19160.00%, and net profit margin of -17253.33%.
Gross Margin100.00%
Operating Margin-19160.00%
Pretax Margin-17253.33%
Net Profit Margin-17253.33%
EBITDA Margin-17028.00%
EBIT Margin-17253.33%
Analyst Forecast
The average price target for Celldex is $54.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$54.90
Price Target Upside86.54% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast-73.94%
EPS Growth Forecast-31.70%